Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care.
暂无分享,去创建一个
[1] G. Lip,et al. Treatment of hypertension in peripheral arterial disease. , 2013, The Cochrane database of systematic reviews.
[2] J. Ehrman,et al. Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication Exercise Versus Endoluminal Revascularization (CLEVER) Study , 2012, Circulation.
[3] P. Branco,et al. Ankle--brachial index, vascular calcifications and mortality in dialysis patients. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] John V. White,et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) , 2011, Vascular medicine.
[5] John V. White,et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.
[6] C. Espinola‐Klein,et al. &bgr;-Blockers in Patients With Intermittent Claudication and Arterial Hypertension: Results From the Nebivolol or Metoprolol in Arterial Occlusive Disease Trial , 2011, Hypertension.
[7] Michael E. Miller,et al. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .
[8] T. Etgen,et al. Relationship between kidney function and risk of asymptomatic peripheral arterial disease in elderly subjects. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] S. Duval,et al. Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. , 2010, Journal of the American College of Cardiology.
[10] A. Cheung,et al. Blood pressure control in type 2 diabetes mellitus. , 2010, American Journal of Kidney Diseases.
[11] R. Bonow,et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I , 2010, Journal of vascular surgery.
[12] A. Cass. Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. , 2010, American heart journal.
[13] M. Tonelli,et al. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] Chuan-Sheng Wang,et al. Ankle brachial index as a predictor for mortality in patients with chronic kidney disease and undergoing haemodialysis , 2010, Nephrology.
[15] D. Hu,et al. Peripheral arterial disease, chronic kidney disease, and mortality: the Chinese Ankle Brachial Index Cohort Study. , 2010, Vascular medicine.
[16] Lian‐Yu Lin,et al. Association of low glomerular filtration rate and albuminuria with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999-2004. , 2010, Atherosclerosis.
[17] M. Venermo,et al. PAD as a risk factor for mortality among patients with elevated ABI--a clinical study. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[18] G. LaMuraglia,et al. Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. , 2009, Journal of vascular surgery.
[19] Hiroshi Takahashi,et al. Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients. , 2010, Clinical therapeutics.
[20] W. März,et al. Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients , 2009, Circulation.
[21] T. Nishibe,et al. Stent placement in the superficial femoral artery for patients on chronic hemodialysis with peripheral artery disease. , 2009, International angiology : a journal of the International Union of Angiology.
[22] M. Woodward,et al. Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. , 2009, The American journal of cardiology.
[23] M. Kamalesh,et al. Diabetes and Peripheral Arterial Disease in Men: Trends in Prevalence, Mortality, and Effect of Concomitant Coronary Disease , 2009, Clinical cardiology.
[24] A. Go,et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[25] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[26] R. Thadhani,et al. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.
[27] M. Koelemay,et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. , 2009, JAMA.
[28] Luigi Ferrucci,et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. , 2009, JAMA.
[29] M. Criqui,et al. Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? , 2008, Circulation.
[30] Hiroshi Takahashi,et al. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] Loki Natarajan,et al. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. , 2008, Journal of vascular surgery.
[32] A. Folsom,et al. Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA). , 2008, Atherosclerosis.
[33] J. Bartholomew,et al. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[34] Hiroshi Takahashi,et al. Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[35] David J Cohen,et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. , 2008, Journal of vascular surgery.
[36] T Rantanen,et al. Prevalence and risk factors of PAD among patients with elevated ABI. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[37] William R Hiatt,et al. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. , 2008, Journal of the American College of Cardiology.
[38] J. Price,et al. Lipid-lowering for peripheral arterial disease of the lower limb. , 2007, The Cochrane database of systematic reviews.
[39] J. Bragg-Gresham,et al. Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] N. Powe,et al. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients. , 2007, Advances in chronic kidney disease.
[41] G. Parrinello,et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[42] A. Folsom,et al. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. , 2007, Journal of the American Society of Nephrology : JASN.
[43] Nelson De Luccia,et al. An updated meta-analysis of infrainguinal arterial reconstruction in patients with end-stage renal disease. , 2001, Journal of vascular surgery.
[44] W. Howard. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. , 2007, Journal of vascular surgery.
[45] D. Mikhailidis,et al. Cilostazol for peripheral arterial disease. , 2007, The Cochrane database of systematic reviews.
[46] John V. White,et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[47] S. Rajagopalan,et al. Peripheral Arterial Disease in Patients With End-Stage Renal Disease: Observations From the Dialysis Outcomes and Practice Patterns Study (DOPPS) , 2006, Circulation.
[48] Mark E. Williams,et al. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. , 2006, Kidney international.
[49] A. Sharrett,et al. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. , 2006, Diabetes care.
[50] Jeroen J. Bax,et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. , 2006, Journal of the American College of Cardiology.
[51] M. Chren,et al. Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[52] Rodney A. White,et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.
[53] U. P. S. T. Force. Screening for peripheral arterial disease: recommendation statement. , 2006, American family physician.
[54] A. Panju,et al. Does the clinical examination predict lower extremity peripheral arterial disease? , 2006, JAMA.
[55] A. Newman,et al. Mortality and Cardiovascular Risk Across the Ankle-Arm Index Spectrum: Results From the Cardiovascular Health Study , 2006, Circulation.
[56] Lu Tian,et al. Physical Performance in Peripheral Arterial Disease: A Slower Rate of Decline in Patients Who Walk More , 2006, Annals of Internal Medicine.
[57] J. Schaal,et al. Risk factors for survival in patients with end-stage renal disease undergoing infrainguinal bypass surgery. , 2005, VASA. Zeitschrift fur Gefasskrankheiten.
[58] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[59] P. Bacchetti,et al. Low ankle-brachial index associated with rise in creatinine level over time: results from the atherosclerosis risk in communities study. , 2005, Archives of internal medicine.
[60] M. Simoons,et al. The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. , 2005, European heart journal.
[61] K. D. Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[62] G. Beck,et al. The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.
[63] M. Chren,et al. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. , 2005, Journal of the American Society of Nephrology : JASN.
[64] A. Murray,et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.
[65] K. Johansen. Exercise and Chronic Kidney Disease , 2005, Sports medicine.
[66] W. O'Fallon,et al. Peripheral arterial disease, diabetes, and mortality. , 2004, Diabetes care.
[67] G. Lip,et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[68] M. Rocco,et al. Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. , 2004, Diabetes care.
[69] Elizabeth Selvin,et al. Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.
[70] O. Wagner,et al. Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. , 2004, Atherosclerosis.
[71] O. Wagner,et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. , 2004, European heart journal.
[72] J. Feinglass,et al. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. , 2004, Journal of vascular surgery.
[73] E. Vittinghoff,et al. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). , 2004, Journal of the American Society of Nephrology : JASN.
[74] C. Gullion,et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.
[75] Richard B Devereux,et al. Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.
[76] N. Powe,et al. Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients. , 2004, Kidney international.
[77] J. Feinglass,et al. Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.
[78] C. Fox,et al. High Prevalence of Peripheral Arterial Disease in Persons With Renal Insufficiency: Results From the National Health and Nutrition Examination Survey 1999–2000 , 2004, Circulation.
[79] J. Adams,et al. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects , 1993, Diabetologia.
[80] M. Shlipak,et al. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. , 2003, Journal of the American Society of Nephrology : JASN.
[81] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[82] P. Roderick,et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[83] Mark A. Creager,et al. Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease , 2003, Circulation.
[84] W. Aronow,et al. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. , 2003, The American journal of cardiology.
[85] G. London,et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[86] J. Bargman,et al. Chiropody May Prevent Amputations in Diabetic Patients on Peritoneal Dialysis , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[87] J. Feinglass,et al. Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs' National Surgical Quality Improvement Program. , 2003, Journal of the American Society of Nephrology : JASN.
[88] R. Kronmal,et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.
[89] R. Foley,et al. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. , 2003, Kidney international.
[90] S. Mondillo,et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. , 2003, The American journal of medicine.
[91] Jin-Bor Chen,et al. Hyperhomocystinemia and the Prevalence of Symptomatic Atherosclerotic Vascular Disease in Taiwanese Chronic Hemodialysis Patients: A Retrospective Study , 2003, Renal failure.
[92] Knut Kröger,et al. Toe Pressure Measurements Compared to Ankle Artery Pressure Measurements , 2003, Angiology.
[93] H. Shigematsu,et al. Infrainguinal arterial reconstruction for limb salvage in patients with end-stage renal disease. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[94] P. Thompson,et al. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication , 2002 .
[95] J. Ware,et al. Effect of Cilostazol on Treadmill Walking, Community‐Based Walking Ability, and Health‐Related Quality of Life in Patients with Intermittent Claudication Due to Peripheral Arterial Disease: Meta‐Analysis of Six Randomized Controlled Trials , 2002, Journal of the American Geriatrics Society.
[96] F. Logerfo,et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. , 2002, Journal of vascular surgery.
[97] T. Lehtimäki,et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[98] G. Johnson,et al. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[99] B. Psaty,et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. , 2002, Kidney international.
[100] K. Johansen,et al. Peripheral vascular disease risk factors among patients undergoing hemodialysis. , 2002, Journal of the American Society of Nephrology : JASN.
[101] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[102] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[103] K. Johansen,et al. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. , 2001, Journal of the American Society of Nephrology : JASN.
[104] W. Bloembergen,et al. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[105] L. Sharma,et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. , 2001, JAMA.
[106] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[107] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[108] M. Criqui,et al. Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .
[109] C. Schmid,et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.
[110] L. Szczech,et al. Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[111] M. Donaldson,et al. Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes? , 2001, Journal of vascular surgery.
[112] M J Koelemay,et al. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. , 2001, JAMA.
[113] M. Rocco,et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. , 2000, Kidney international.
[114] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[115] B. Manns,et al. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[116] J. Pugh,et al. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. , 1999, Kidney international.
[117] M. Prins,et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. , 1999, Archives of internal medicine.
[118] M. Caron,et al. Realistic expectations for pedal bypass grafts in patients with end-stage renal disease. , 1998, Journal of vascular surgery.
[119] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[120] J. Kjekshus,et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). , 1998, The American journal of cardiology.
[121] A. Testa,et al. [Ankle-arm blood pressure index (AABPI) in hemodialysis patients]. , 1997, Archives des maladies du coeur et des vaisseaux.
[122] R B D'Agostino,et al. Intermittent claudication. A risk profile from The Framingham Heart Study. , 1997, Circulation.
[123] M. Dennis. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .
[124] P. Morris,et al. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[125] S. Fishbane,et al. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[126] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[127] D. Bandyk,et al. Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. , 1995, Journal of vascular surgery.
[128] P. Watkins,et al. Reduction of Gangrene and Amputations in Diabetic Renal Transplant Patients: the Role of a Special Foot Clinic , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[129] David C. Murray,et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. , 1995, Kidney international.
[130] D. Bild,et al. Reduction of Lower Extremity Clinical Abnormalities in Patients with Non-Insulin-Dependent Diabetes Mellitus , 1993, Annals of Internal Medicine.
[131] J. Hallett. β-Adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: Radack K, Deck C. Arch Intern Med 1991;151:1769–1776 , 1993 .
[132] M. Donaldson,et al. Infrainguinal reconstruction for patients with chronic renal insufficiency. , 1993, Journal of vascular surgery.
[133] G. Clagett,et al. Antithrombotic therapy in peripheral arterial occlusive disease. , 1992, Chest.
[134] R. Langer,et al. Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.
[135] K. Radack,et al. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. , 1991, Archives of internal medicine.
[136] R. Prescott,et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.
[137] J. Rice,et al. Infrainguinal Revascularization for Limb Salvage in Patients With End‐Stage Renal Disease , 1991, Southern medical journal.
[138] J. Regensteiner,et al. Benefit of exercise conditioning for patients with peripheral arterial disease. , 1990, Circulation.
[139] W. Whitehouse. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality: Jonason T, Bergstrom R. Acta Med Scand 1987;221:253–260 , 1988 .
[140] P. McCollum,et al. Assessment of arterial disease using digital systolic pressure measurement. , 1988, Annals of vascular surgery.
[141] R. Bergström,et al. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. , 2009, Acta medica Scandinavica.
[142] L T Cotton,et al. Improved survival of the diabetic foot: the role of a specialized foot clinic. , 1986, The Quarterly journal of medicine.
[143] V. Bernhard,et al. Noninvasive assessment of toe systolic pressures with special reference to diabetes mellitus. , 1983, The Journal of cardiovascular surgery.
[144] L. Cotton,et al. The measured effect of stopping smoking on intermittent claudication , 1982, The British journal of surgery.